These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37075902)

  • 1. Assessment of medication adherence after enrollment in a health system funded medication assistance program for patients with diabetes.
    Franck L; Donovan A; Kellison M; McAdam-Marx C
    J Am Pharm Assoc (2003); 2023; 63(4):1222-1229.e3. PubMed ID: 37075902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
    Peaslee A; Wickizer M; Olson J; Topp R
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
    McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
    J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
    Pednekar P; Heller DA; Peterson AM
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
    McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
    J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of medication adherence and health care utilization among patients with chronic disease who were enrolled in a pharmacy assistance program.
    Roberts AW; Crisp GD; Esserman DA; Roth MT; Weinberger M; Farley JF
    N C Med J; 2014; 75(5):310-8. PubMed ID: 25237868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.
    Lawrence DB; Ragucci KR; Long LB; Parris BS; Helfer LA
    J Manag Care Pharm; 2006; 12(6):466-71. PubMed ID: 16925454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors.
    Rascati KL; Worley K; Meah Y; Everhart D
    J Manag Care Spec Pharm; 2017 Mar; 23(3):299-306. PubMed ID: 28230454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors.
    Lauffenburger JC; Franklin JM; Krumme AA; Shrank WH; Matlin OS; Spettell CM; Brill G; Choudhry NK
    J Manag Care Spec Pharm; 2018 May; 24(5):469-477. PubMed ID: 29694288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis.
    Shenolikar RA; Balkrishnan R; Camacho FT; Whitmire JT; Anderson RT
    Clin Ther; 2006 Aug; 28(8):1199-1207. PubMed ID: 16982297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and incremental costs from a medication adherence pilot intervention targeting low-income patients with diabetes at risk of cost-related medication nonadherence.
    Ryan JG; Fedders M; Jennings T; Vittoria I; Yanes M
    Clin Ther; 2014 Dec; 36(12):1991-2002. PubMed ID: 25282579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial burden and medication adherence among near-poor older adults in a pharmaceutical assistance program.
    Kim NH; Look KA; Dague L; Winn AN
    Res Social Adm Pharm; 2022 Mar; 18(3):2517-2523. PubMed ID: 34030976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.